Avinger (NASDAQ:AVGR) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Avinger (NASDAQ:AVGR – Get Rating) in a report issued on Wednesday. The firm issued a sell rating on the medical device company’s stock.

Avinger Stock Down 5.3 %

Shares of NASDAQ AVGR opened at $0.91 on Wednesday. Avinger has a 1 year low of $0.86 and a 1 year high of $4.20. The firm has a 50-day simple moving average of $1.23 and a two-hundred day simple moving average of $1.20. The company has a market cap of $6.77 million, a P/E ratio of -0.19 and a beta of 1.52. The company has a debt-to-equity ratio of 2.76, a current ratio of 3.48 and a quick ratio of 2.76.

Hedge Funds Weigh In On Avinger

Several hedge funds have recently bought and sold shares of the business. Dimensional Fund Advisors LP purchased a new stake in shares of Avinger during the first quarter valued at $64,000. Renaissance Technologies LLC purchased a new stake in Avinger in the 2nd quarter valued at about $42,000. Finally, Armistice Capital LLC purchased a new stake in Avinger in the 3rd quarter valued at about $768,000. Institutional investors own 14.14% of the company’s stock.

Avinger Company Profile

(Get Rating)

Avinger, Inc is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. Its products include Pantheris, Lightbox, Ocelot, Wildcat, Juicebox, and Kittycat.